Volume 70, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Anti-malarial drugs have been used in various ways to prevent malaria in the resident populations of endemic areas for nearly 100 years. The primary aim of most early studies was to interrupt transmission. This was rarely achieved, but administration of anti-malarial drugs either through medication of salt or by mass administration frequently led to a marked reduction in the prevalence of malaria infection and in the incidence of clinical attacks. Chemoprophylaxis is highly effective in reducing mortality and morbidity from malaria in young children and pregnant women living in endemic areas, but is difficult to sustain and, in some studies, has impaired the development of naturally acquired immunity. Intermittent preventive treatment, in which full therapeutic doses of a drug are given at defined intervals, has the potential to provide some of the benefits of sustained chemoprophylaxis in pregnant women and young children without some of its drawbacks and is a promising new approach to malaria control.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Harrison G, 1978. Mosquitoes, Malaria and Man; A History of the Hostilities Since 1880. London: John Murray.
  2. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, 2000. Effects of artesunate mefloquine combination on incidence of Plasmodium falciparum and mefloquine resistance in western Thailand: a prospective study. Lancet 356 : 297–302. [Google Scholar]
  3. Hung LQ, de Vries PJ, Giao PT, Nam NV, Binh TQ, Chong MT, Quoc NTTA, Thanh TN, Hung LN, Kager PA, 2002. Control of malaria; a successful experience from Vietnam. Bull World Health Organ 80 : 660–666. [Google Scholar]
  4. Barnes KI, Durrheim DN, Jackson A, Mehta U, Tsoka J, Diamini SS, Qwabe B, Bredenkamp B, Nettleship E, Mthembu D, Mthembu DJ, Sharp BL, 2003. Epidemiology of malaria following implementation of artemether-lumefantrine as first-line treatment of uncomplicated disease in KwaZulu-Natal, South Africa. Antibiot Chemother 7 : 6. [Google Scholar]
  5. Von Seidlein L, Clarke S, Alexander N, Manneh F, Doherty T, Pinder M, Walraven G, Greenwood BM, 2002. Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. Bull World Health Organ 80 : 790–796. [Google Scholar]
  6. Barber MA, Rice JB, Brown JY, 1932. Malaria studies on the Firestone rubber plantation in Liberia, West Africa. Am J Hyg 15 : 601–623. [Google Scholar]
  7. Von Seidlein L, Greenwood BM, 2003. Mass administration of antimalarial drugs. Trends Parasito 19 : 452–460. [Google Scholar]
  8. Molineaux L, Gramiccia G, 1980. The Garki Project. Geneva: World Health Organization.
  9. Garfield RM, Vermund SH, 1983. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet ii : 500–503. [Google Scholar]
  10. Von Seidlein L, Walraven G, Milligan PLM, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin S, Olliaro P, Bennett S, Schimm M, Okunoye K, Targett GAT, McAdam KPWJ, Doherty JF, Greenwood BM, Pinder M, 2003. The effect of mass administration of pyrimethamine/sulphadoxine combined with artesunate on malaria transmission: a double blind, community randomised, placebo controlled trial in The Gambia. Trans R Soc Trop Med Hyg 97 : 217–225. [Google Scholar]
  11. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Björkman A, 2000. Malaria eradication on islands. Lancet 356 : 1560–1564. [Google Scholar]
  12. Pinotti M, 1954. Chemoprophylaxis of malaria by the association of an antimalarial drug to the sodium chloride used daily in the preparation of meals. Fifth International Congress of Tropical Medicine and Malaria, 1953. Volume 2. Instanbul, Turkey, 248–258.
  13. Payne D, 1988. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol Today 4 : 112–115. [Google Scholar]
  14. Meuwissen JHET, 1964. The use of medicated salt in an antimalaria campaign in West New Guinea. Trop Geogr Med 16 : 245–255. [Google Scholar]
  15. Giglioli G, Rutten FJ, Ramjattan S, 1967. Interruption of malaria transmission by chloroquinized salt in Guyana with observations on a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 36 : 283–301. [Google Scholar]
  16. McGregor IA, Gilles HM, Walter JH, Davies AH, Pearson FA, 1956. Effects of heavy and repeated malaria infections on Gambian infants and children. Effects of erythrocytic parasitization. BMJ ii : 686–692. [Google Scholar]
  17. Prinsen Geerlins PD, Brabin BJ, Eggelte TA, 2003. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ 81 : 205–216. [Google Scholar]
  18. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, Hayes RJ, N’Jie ABH, 1988. Comparison of two strategies for control of malaria within a primary health care programme in The Gambia. Lancet i : 1121–1127. [Google Scholar]
  19. Allen SJ, Snow RW, Menon A, Greenwood BM, 1990. Compliance with malaria chemoprophylaxis over a five year period among children in a rural are of the Gambia. J Trop Med Hyg 93 : 313–322. [Google Scholar]
  20. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F, Acosta CJ, Schellenberg DM, Galindo CM, Kimario J, Urassa, Brabin B, Smith TA, Kitua AY, Tanner M, Alonso PL, 1997. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350 : 844–850. [Google Scholar]
  21. Morley D, Woodland M, Cuthbertson WFJ, 1964. Controlled trial of pyrimethamine in pregnant women in an African village. BMJ i : 67–68. [Google Scholar]
  22. Garner P, Gülmezoglu AM, 2001.Prevention Versus Treatment for Malaria in Pregnant Women (Cochrane Review). The Cochrane Library, Issue 4. Oxford: Update Software.
  23. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib N’Jie AB, 1989. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 83 : 589–594. [Google Scholar]
  24. David KP, Marbiah NT, Lovtren P, Greenwood BM, 1997. Hyperpigmented dermal macules in children following the administration of MaloprimR for malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 91: 204–208. [Google Scholar]
  25. Goodman CA, Coleman PG, Mills AJ, 1999. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354 : 378–385. [Google Scholar]
  26. Greenwood BM, David PH, Otoo-Forbes L, Allen SJ, Alonso PL, Armstrong-Schellenberg JR, Byass P, Hurwitz M, Menon A, Snow RW, 1995. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 89 : 629–633. [Google Scholar]
  27. Staalsoe T, Megnekou R, Fievét N, Ricke CH, Zornig HD, Leke R, Taylor DW, Deloron P, Hviid L, 2001. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 184 : 618–626. [Google Scholar]
  28. Greenwood AM, Menendez C, Alonso PL, Jaffar S, Langerock P, Lulat S, Todd J, M’Boge B, Francis N, Greenwood BM, 1994. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 88 : 681–682. [Google Scholar]
  29. Lemnge MM, Msangeni HA, Rønn AM, Salum FM, Jakobsen PH, Mhina JI, Akida JA, Bygbjerg, 1997. Maloprim R malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania. Trans R Soc Trop Med Hyg 91 : 68–73. [Google Scholar]
  30. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51 : 515–522. [Google Scholar]
  31. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux M, 2000. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997–99. Trans R Soc Trop Med Hyg 94 : 549–553. [Google Scholar]
  32. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K, 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy. Lancet 353 : 632–636. [Google Scholar]
  33. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW, 1998. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59 : 813–822. [Google Scholar]
  34. Schellenberg D, Menendez C, Kahigwa E, Aponte JJ, Vidal J, Tanner M, Mshinda H, Alonso P, 2001. Intermittent treatment for malaria and anaemia control at time of routine vaccination in Tanzanian infants; a randomised, placebo-controlled trial. Lancet 357 : 1471–1477. [Google Scholar]
  35. Massaga JJ, Kitua AY, Lemnge M, Akida JA, Malle LN, Rønn AM, Theander TG, Bygbjerg IC, 2003. Effect of intermittent treatment with amodiaquine on anaemia and malaria fevers in Tanzania; a randomised, placebo-controlled trial. Lancet 361 : 1853–1860. [Google Scholar]

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error